Wharton Business Group Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Wharton Business Group reduced its stake in Stryker Corporation by 3.07% during the most recent quarter end. The investment management company now holds a total of 9,630 shares of Stryker Corporation which is valued at $1,112,554 after selling 305 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Aug 8, 2016.Stryker Corporation makes up approximately 0.12% of Wharton Business Group’s portfolio.

Other Hedge Funds, Including , Assetmark Inc reduced its stake in SYK by selling 176 shares or 11.79% in the most recent quarter. The Hedge Fund company now holds 1,317 shares of SYK which is valued at $152,153.Connable Office Inc reduced its stake in SYK by selling 817 shares or 2.35% in the most recent quarter. The Hedge Fund company now holds 34,001 shares of SYK which is valued at $3,906,715. Stryker Corporation makes up approx 1.05% of Connable Office Inc’s portfolio.Mitsubishi Ufj Kokusai Asset Management Ltd. boosted its stake in SYK in the latest quarter, The investment management firm added 1,038 additional shares and now holds a total of 49,944 shares of Stryker Corporation which is valued at $5,734,570. Stryker Corporation makes up approx 0.14% of Mitsubishi Ufj Kokusai Asset Management Ltd.’s portfolio.Boston Private Wealth reduced its stake in SYK by selling 8,474 shares or 3.21% in the most recent quarter. The Hedge Fund company now holds 255,700 shares of SYK which is valued at $29,359,474. Stryker Corporation makes up approx 1.16% of Boston Private Wealth’s portfolio. Donald L. Hagan sold out all of its stake in SYK during the most recent quarter. The investment firm sold 750 shares of SYK which is valued $87,773.

Stryker Corporation closed down -0.34 points or -0.29% at $115.23 with 5,68,638 shares getting traded on Monday. Post opening the session at $115.5, the shares hit an intraday low of $115.23 and an intraday high of $115.8 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *